NCT04626024 2025-12-19
TOKIN
Baylor College of Medicine
Phase 2 Recruiting
Clinical Trials
6 trialsNCT03831776 2025-06-08
BosuPeg
St. Olavs Hospital
Phase 2 Completed
NCT02311998 2023-07-17
Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02810990 2023-02-03
BEST
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed
NCT03885830 2023-01-11
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
UNC Lineberger Comprehensive Cancer Center
Completed
NCT03205267 2017-07-02
BODO
University of Bonn
Phase 2 Unknown